Synopsys (SNPS) Reports In-Line Q3 EPS; Issues Strong Q1, FY13 Revs Outlook
Get Alerts SNPS Hot Sheet
Price: $421.50 +2.37%
EPS Growth %: +8.3%
Financial Fact:
Amortization of intangible assets: 22.57M
Today's EPS Names:
SVBT, ZEO, OTLK, More
EPS Growth %: +8.3%
Financial Fact:
Amortization of intangible assets: 22.57M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Join SI Premium – FREE
Synopsys, Inc. (NASDAQ: SNPS) reported Q3 EPS of $0.47, in-line with the analyst estimate of $0.47. Revenue for the quarter came in at $454.2 million versus the consensus estimate of $445.63 million.
Synopsys, Inc. sees Q1 2013 EPS of $0.54-0.56, versus the consensus of $0.55. Synopsys, Inc. sees Q1 2013 revenue of $468-478 million, versus the consensus of $459.98 million.
Synopsys, Inc. sees FY2013 EPS of $2.26-2.31, versus the consensus of $2.28. Synopsys, Inc. sees FY2013 revenue of $1.955-1.975 billion, versus the consensus of $1.88 billion.
For earnings history and earnings-related data on Synopsys, Inc. (SNPS) click here.
Synopsys, Inc. sees Q1 2013 EPS of $0.54-0.56, versus the consensus of $0.55. Synopsys, Inc. sees Q1 2013 revenue of $468-478 million, versus the consensus of $459.98 million.
Synopsys, Inc. sees FY2013 EPS of $2.26-2.31, versus the consensus of $2.28. Synopsys, Inc. sees FY2013 revenue of $1.955-1.975 billion, versus the consensus of $1.88 billion.
For earnings history and earnings-related data on Synopsys, Inc. (SNPS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
- Vivos Therapeutics posts 35% revenue gain but widens net loss
- Hydrofarm Holdings Group, Inc. (HYFM) Misses Q2 EPS by 134c
Create E-mail Alert Related Categories
Earnings, Guidance, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share